循环RNA导向的治疗策略,用于感冒引起的糖尿病大血管疾病
Nan Jia1, Kangling Xie1, Cui Li1
1Department of Rehabilitation, National Regional Center for Neurological Diseases, Xiangya Hospital, Central South University, Nanchang, China.
这项研究表明,用黄金纳米颗粒 (AuNPs) 介导的反感性寡核酸 (ASOs) 和有氧运动准hsa_circ_0010154可以缓解糖尿病大血管疾病 (DM-MVD). 这种新的方法改善了新陈代谢健康,并减少了氧化应激.
科学领域:
- 分子生物学分子生物学
- 纳米医学是一种纳米医学.
- 心血管疾病研究研究
背景情况:
- 糖尿病大血管疾病 (DM-MVD) 是一种严重的并发症,特别是在寒冷的气候.
- hsa_circ_0010154在DM-MVD中被上调,这表明它在疾病发病过程中的作用.
- 目前对DM-MVD的治疗有局限性,需要新的治疗策略.
研究的目的:
- 通过针对 hsa_circ_0010154.4 来研究缓解寒冷气候引起的DM-MVD的分子机制.
- 为了评估黄金纳米颗粒 (AuNPs) 介导的反感性寡核酸 (ASOs) 输送与有氧运动相结合的治疗效果.
- 探索对葡萄糖/脂质代谢,炎症和氧化应激的影响.
主要方法:
- 生物信息学分析和qRT-PCR以确认hsa_circ_0010154上调.
- 开发AuNPs@ASO复合体,用于有针对性的输送和反应性氧物种响应的释放.
- 关于内皮细胞功能的体外研究和关于心脏和血管健康的体内研究.
主要成果:
- 沉默hsa_circ_0010154改善了内皮功能,减少了炎症,并增强了脂质代谢.
- AuNPs@ASO证明了有效的细胞吸收和有针对性的释放.
- 联合治疗改善了心脏功能,血管重塑和体内抗氧化活性.
结论:
- 用AuNPs@ASO和有氧运动准hsa_circ_0010154是一个有希望的DM-MVD治疗策略.
- 这种方法有效调节关键的病理途径,提供精确和低毒性治疗.
- 这些发现对DM-MVD疗法的临床转化有重大影响.
更多相关视频
10:07Studying Diabetes Through the Eyes of a Fish: Microdissection, Visualization, and Analysis of the Adult tgfli:EGFP Zebrafish Retinal Vasculature
Published on: December 26, 2017
07:01Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
相关概念视频
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Experimental RNAi
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
